RIGA - The revenue of the pharmaceutical company, joint-stock Olainfarm Group, in 2019 has reached 137,219,000 euros, which is a 10 percent increase compared to 2018, according to the company's announcement to the Nasdaq Riga Stock Exchange.
The Group's net profit in 2019 was 23,628,000 euros, which is historically the largest amount of the Group's net profit.
For 2019, the Board will recommend paying 0.32 euros per share in dividends to shareholders.
For 2020, the group plans a turnover of 135.5 million euros and a net pr...
The article you requested can be accessed only by subscribing to the online version of The Baltic Times. If you are already subscribed to The Baltic Times, please authorize yourself.
In case you don't have a subscription yet - please visit our SUBSCRIPTION